Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2001. Start Trial.
Date Value
October 23, 2026 122.11B
October 22, 2026 123.05B
October 21, 2026 120.64B
October 20, 2026 121.87B
October 19, 2026 119.51B
October 16, 2026 119.61B
October 15, 2026 118.62B
October 14, 2026 116.29B
October 13, 2026 113.05B
October 12, 2026 114.37B
October 09, 2026 113.52B
October 08, 2026 113.60B
October 07, 2026 114.57B
October 06, 2026 113.72B
October 05, 2026 113.62B
October 02, 2026 114.59B
October 01, 2026 114.89B
September 30, 2026 116.90B
September 29, 2026 119.28B
September 28, 2026 119.99B
September 25, 2026 119.06B
September 24, 2026 119.89B
September 23, 2026 120.01B
September 22, 2026 122.05B
September 21, 2026 122.78B
Date Value
September 18, 2026 121.04B
September 17, 2026 122.74B
September 16, 2026 121.18B
September 15, 2026 120.62B
September 14, 2026 120.70B
September 11, 2026 116.82B
September 10, 2026 116.79B
September 09, 2026 117.83B
September 08, 2026 117.64B
September 04, 2026 120.38B
September 03, 2026 122.36B
September 02, 2026 121.49B
September 01, 2026 121.93B
August 31, 2026 121.10B
August 28, 2026 122.26B
August 27, 2026 121.14B
August 26, 2026 123.49B
August 25, 2026 124.78B
August 24, 2026 124.20B
August 21, 2026 125.47B
August 20, 2026 124.56B
August 19, 2026 126.42B
August 18, 2026 122.92B
August 17, 2026 121.16B
August 14, 2026 119.63B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
AstraZeneca PLC 558.20B
Johnson & Johnson 662.44B
Eli Lilly & Co. 1.245T
Merck & Co., Inc. 405.39B
Novo Nordisk A/S 145.21B